
    
      The aim of the study will be to evaluate the impact on functional motor abilities of
      intrathecally-injected nusinersen in adult 5q-SMA type 2 and type 3 persons.

      If the efficacy of nusinersen protocol will demonstrate the positive impact for patient's,
      the results of this study would promote an improvement in the medical service rendered in
      this population in terms of disease stabilization, maintenance of functional capacities and
      social participation.
    
  